American Shared Hospital Services (AMS)
AMEXHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
$1.43-2.05%
Close 2026-09-04 · 1-day change
AMEXHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
QuarterlyIQ Insights · AMS
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -69.9% |
| Our one-year growth estimate | diamond | 3.0% |
Growth built into the price is above our model estimate.
The price assumes 72.9 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Worth watching into the next print: this name is a smaller-cap name (higher miss base rate) and has erratic recent earnings surprises. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 27 industry peers · Company calendar date is not available
AMS — earnings miss
Dated 2026-08-13
Results of Operations and Financial Condition. On August 13, 2026, the Company issued a press release announcing its financial results for the second quarter ending June 30, 2026. The full text of the press release is furnished as Exhibit 99.1 to this report. The Company does not intend for this exhibit to be incorporated by reference into future filings under the Securities Exchange Act of 1934.
Why it matters: Strong growth in Direct Patient Services shows demand for cancer treatment is rising. This supports the company's growth strategy.
Supportive ifDirect Patient Services revenue growth exceeds 35% year over year in Q3.
Worry ifDirect Patient Services revenue growth falls below 30% year over year in Q3.
Why it matters: Better cash flow shows stronger financial health and better operations.
Supportive ifCash from operations was more than $2.5 million.
Worry ifCash from operations was less than $2.5 million.
Why it matters: A rise in net loss may mean worse money problems and challenges in operations.
Worry ifNet loss exceeds $600,000 in Q3.
Less concerning ifNet loss remains below $600,000 in Q3.
Why it matters: A drop in volumes may show less need for radiation therapy services.
Worry ifGamma Knife procedures are down year over year.
Less concerning ifGamma Knife procedures are up year over year.
Why it matters: A new CFO could change how the company manages its finances and growth plans.
Watch forNew CFO announces a clear strategy for improving cash flow and growth.
Also watch forThe new CFO did not share a plan. This causes uncertainty in managing finances.
Why it matters: Changes in leadership can change the company and how investors feel. Clear news can help shares.
Watch forThe company announces a new CEO who outlines a clear growth strategy.
Also watch forUnclear leadership can cause more uncertainty or bad news.
Why it matters: A new CFO can impact financial strategy and stability. Delays in this appointment may signal internal issues.
Watch forAnnouncement of a new CFO appointment.
Also watch forNo announcement of a new CFO within the next quarter.
Why it matters: A drop in cash flow may show problems with how the company runs and its money health.
Worry ifOperating cash flow drops below $2 million in Q3.
Less concerning ifOperating cash flow remains above $2 million in Q3.
Why it matters: This growth shows how well the company is performing in a key treatment area. A slowdown could raise concerns.
Worry ifProton Beam Radiation Therapy revenue growth below 20% year over year.
Less concerning ifProton Beam Radiation Therapy revenue growth at or above 20% year over year.
Why it matters: Improving the balance sheet is crucial for long-term growth. It impacts the ability to invest in new technologies.
Supportive ifCash and equivalents increase to over $8 million in Q3.
Worry ifCash and equivalents drop below $6 million in Q3.
Why it matters: The CFO change may change financial plans and affect how investors feel. This could change stock performance.
Watch forGood comments about the new CFO's plans and vision for the company.
Also watch forNegative feedback or uncertainty about the new CFO's plans.
Why it matters: This will show if the company is growing its business. A strong performance can boost investor confidence.
Supportive ifRevenue from new installations increases year over year in the Q2 earnings report.
Worry ifRevenue from new installations declines year over year in the Q2 earnings report.
Why it matters: Positive cash flow shows the company is improving its financial health. This is key for future growth.
Supportive ifOperating cash flow remains positive and exceeds $2 million in Q3.
Worry ifOperating cash flow turns negative in Q3.
Why it matters: A slowdown in revenue growth could signal weakening demand for AMS's services.
Worry ifQ3 revenue growth below 15% year over year.
Less concerning ifQ3 revenue growth above 15% year over year.
Why it matters: Positive cash flow shows good financial health and management.
Supportive ifCash from operations was over $2.1M for Q2 2026.
Worry ifCash from operations was under $2.1M for Q2 2026.
Why it matters: News on the credit agreement can show if the company is stable or at risk. This affects how the company manages its money.
Watch forGood news on the credit agreement that improves financial options.
Also watch forBad news or delays in the credit agreement process.
Why it matters: CFO changes can impact financial strategy and investor confidence. Stability is key for growth.
Watch forNew CFO announced with a strong background in healthcare finance.
Also watch forNo new CFO appointed or prolonged vacancy in the CFO position.
Why it matters: Recent legal events may affect financial obligations and cash flow. This can impact operations.
Worry ifNew financial obligations arise that increase costs by more than 15%.
Less concerning ifNo new financial obligations or costs remain stable.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$265 on $10,000 · ±2.6% | How much price usually moves either way. |
| Bad day | $585 loss on $10,000 · 5.8% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $5,757 loss on $10,000 · 57.6% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.